Karuna Therapeutics, Inc. Deferred Offering Costs
Karuna Therapeutics, Inc. had Deferred Offering Costs of $200.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredOfferingCosts · last filed 2024-02-22
- 2023-12-31: Deferred Offering Costs $200.00K.
- 2023-09-30: Deferred Offering Costs $829.00K.
- 2023-06-30: Deferred Offering Costs $625.00K.
- 2023-03-31: Deferred Offering Costs $625.00K.
| Period end | Deferred Offering Costs | Deferred Offering Costs as first filed |
|---|---|---|
| 2023-12-31 | $200.00K 10-K · filed 2024-02-22 | |
| 2023-09-30 | $829.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $625.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $625.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $600.00K 10-K · filed 2024-02-22 | $568.00K 10-K · filed 2023-02-23 |
| 2022-09-30 | $528.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $528.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $480.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $455.00K 10-K · filed 2023-02-23 | |
| 2021-09-30 | $405.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $405.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $405.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $405.00K 10-K · filed 2022-02-24 | |
| 2020-09-30 | $405.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $338.00K 10-Q · filed 2020-08-05 | |
| 2019-06-30 | $2.03M 10-Q · filed 2019-08-08 |